Akanda Partners with Cookies to Bring the Iconic Cannabis Brand and High THC Strains to European Consumers for the First Time
September 13 2022 - 7:30AM
Business Wire
Exclusive licensing agreement enables Akanda to
cultivate, manufacture and sell Cookies branded products in
Portugal, including operating Cookies branded pharmacy outlets
International medical cannabis platform company Akanda Corp.
("Akanda" or the “Company”) (NASDAQ: AKAN) today announced an
exclusive license agreement with iconic international cannabis
lifestyle brand Cookies. The multi-year agreement enables Akanda to
pursue the current medical and future adult-use opportunities in
Europe with arguably one of the best-known cannabis brands and
highest quality genetics in the world.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220913005553/en/
Exclusive licensing agreement enables
Akanda to cultivate, manufacture and sell Cookies branded products
in Portugal, including operating Cookies branded pharmacy
outlets
Under the terms of the license agreement, Akanda gains the
ability to cultivate, manufacture and distribute Cookies strains,
and the rights to sell Cookies branded products, including
non-cannabis merchandise, in Portugal. Akanda intends to initially
produce EU GMP certified Cookies branded high THC medical cannabis
products at its flagship indoor premium cultivation and
manufacturing facility in Sintra, Portugal. Additionally, Akanda is
able to exclusively open and operate flagship Cookies branded
pharmacy outlets throughout the country.
Brainchild of rapper and entrepreneur Berner (Gilbert Milam),
who was recently featured on the cover of Forbes, Cookies currently
has over 53 retail locations spanning five total countries
including 12 states in the U.S., selling lifestyle apparel as well
as recreational and medicinal cannabis products as regulations
allow.
“Adding the iconic Cookies brand and their high THC strains to
Akanda’s platform is an important catalyst in our quest to lead the
cannabis industry in Europe. Cookies premium genetics are an
essential pillar to have in our portfolio as these markets begin to
open up. We can’t wait to introduce the brand to consumers in
Portugal, and strains to patients throughout Europe,” commented
Akanda’s CEO Tej Virk.
“The fact that Portugal decriminalized drugs back in the early
2000’s and people in the U.S. are still being locked up for
cannabis 20 years later, shows the world, especially the U.S., that
we can learn a lot from their forward thinking. The partners we
chose in Portugal have one of the most advanced facilities I’ve
seen and will be producing some of the best cannabis in the world.
It’s partnerships like this that keep me excited about the growth
and expansion of Cookies worldwide,” said Berner, Co-Founder and
CEO of Cookies.
“The Cookies license agreement is enabled by our May 2022
acquisition of Portugal-based Holigen, which makes Akanda a
cultivator, manufacturer and distributor of EU GMP certified
medical cannabis with a state-of-the-art 20,000 square foot indoor
cultivation site in Sintra dedicated to the cultivation of high THC
premium cannabis as well as a large seven million square foot (180+
acres) outdoor facility located two hours south in Aljustrel,” Virk
continued. “It is further evidence that Akanda has secured one of
the most prized cannabis assets in Europe. With brands and strains
like Cookies, I’ve never been more confident about Akanda’s
promising future.”
About Cookies
Cookies, founded in 2010 by Billboard-charting rapper and
entrepreneur Berner and Bay Area breeder and cultivator Jai, is the
most globally recognized cannabis company in the world. Cookies
values the power of the plant and focuses on creating game-changing
genetics. The company offers a collection of over 70 proprietary
cannabis cultivars and more than 2,000 products. Cookies also
actively works to enrich communities disproportionately impacted by
the War on Drugs through advocacy and social equity initiatives.
Headquartered in San Francisco, the company opened its first retail
store in 2018 in Los Angeles, and has since expanded to over 50
retail locations in 17 markets across 5 countries. Cookies was
named one of America’s Hottest Brands of 2021 by AdAge; the first
cannabis brand to ever receive this accolade. To learn more about
Cookies, visit cookies.co, and to learn more about Cookies CBD,
visit shop.cookies.co/.
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. Akanda’s
portfolio includes Bophelo Bioscience & Wellness, a GACP
qualified cultivation campus in the Kingdom of Lesotho in Southern
Africa; Holigen, a Portugal-based cultivator, manufacturer and
distributor with a prized EU GMP certified indoor grow facility;
and CanMart, a UK-based fully licensed pharmaceutical importer and
distributor which supplies pharmacies and clinics within the UK.
The Company’s seed-to-patient supply chain also includes
partnerships with Cellen Life Sciences’ Leva Clinic, one of the
first fully digital pain clinics in the UK, and Cantourage, which
operates a platform for bringing medical cannabis to Europe.
Connect with Akanda: Website | LinkedIn | Twitter |
Instagram
Cautionary Note Regarding
Forward-Looking Information and Statements
This press release contains certain "forward-looking
information" within the meaning of applicable Canadian securities
legislation and may also contain statements that may constitute
"forward-looking statements" within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Such forward-looking information and
forward-looking statements are not representative of historical
facts or information or current condition, but instead represent
only Akanda's beliefs regarding future events, plans or objectives,
many of which, by their nature, are inherently uncertain and
outside of Akanda's control. Generally, such forward-looking
information or forward-looking statements can be identified by the
use of forward-looking terminology such as "plans", "expects" or
"does not expect", "is expected", "budget", "scheduled",
"estimates", "forecasts", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or may contain statements that certain actions, events or results
"may", "could", "would", "might" or "will be taken", "will
continue", "will occur" or "will be achieved". Forward-looking
information may relate to anticipated events or results including,
but not limited to business strategy, product development and sales
and growth plans. The forward-looking information and
forward-looking statements contained in this press release are made
as of the date of this press release, and Akanda does not undertake
to update any forward-looking information and/or forward-looking
statements that are contained or referenced herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220913005553/en/
Martha N. Marshall Grasslands: A Journalism-Minded Agency
martha@mygrasslands.com (703) 474-1420
Investors Matt Chesler, CFA FNK IR ir@akandacorp.com
Media Imogen Saunders Irvine Partners
imogen@irvinepartners.co.uk
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Apr 2023 to Apr 2024